Interesting. I'm on a term life policy with a still fixed premium that is set to start rising rapidly in a few yrs (and have wondered if I am insurable with a new policy). I'm also a little over a year out of HDR Brachy with a PSA that was tested recently at 1.4 after 12 months.
If you are treated successfully with surgery your PSA should drop below the 0.2 level. I guess to zero, or close to it. But Brachy patients still have their prostates and their PSA's aren't going to zero. Isn't it often the case that nadir will be above 0.2.? Which won't be a cause for concern - but would seem to disqualify for insurance if insurers are using the same PSA standards for surgery and brachy patients.
riskquoter said...
I know this is an older thread, but there are some differences in how life insurance underwriting views prostate cancer treatment options.
If you are talking about confined prostate cancers - stage T1a - T2b with Gleason of 7 (3+4) or less and negative margins, coverage may be available as soon as 4 months after a radical prostatectomy.
If brachy is the treatment option, companies will postpone for a period of time after completion of brachy, (typically 1 year minimum) and the availability of coverage is dependent on current PSA being 0.2 or less....same rules apply to other forms of radiation treatment.